________
Source: State of the Nation
HUGE!!! COVID TREATMENT COVER-UP BLOWN WIDE OPEN!
EPIC MSM INTERVIEW EXPOSES MASSIVE, MONOLITHIC & ONGOING COVID-19 TREATMENT COVER-UP
June 21, 2021 by State of the Nation
State of the Nation
Folks, if there is one mainstream media interview that MUST be watched TODAY … and posted everywhere TODAY … and disseminated everywhere TODAY, this is the one.
The following FOX News interview conducted by Maria Bartiromo with US Senator Ron Johnson and COVID-19 Specialist Dr. Pierre Kory revealed some of the most radioactive Covid conspiracy and cover-up truths ever by the MSM. The raw and indisputable facts disclosed in just over 16 minutes is as shocking as they are breathtaking BECAUSE THEY ARE BEING DIVULGED BY THE MAINSTREAM MEDIA!
Now, sit back, grab your popcorn, and watch the show before the real fireworks explode all over Washington, D.C.
Go to http://stateofthenation.co/?p=70066 to view the video news clip.
Folks, if there is one mainstream media interview that MUST be watched TODAY … and posted everywhere TODAY … and disseminated everywhere TODAY, this is the one.
The following FOX News interview conducted by Maria Bartiromo with US Senator Ron Johnson and COVID-19 Specialist Dr. Pierre Kory revealed some of the most radioactive Covid conspiracy and cover-up truths ever by the MSM. The raw and indisputable facts disclosed in just over 16 minutes is as shocking as they are breathtaking BECAUSE THEY ARE BEING DIVULGED BY THE MAINSTREAM MEDIA!
Now, sit back, grab your popcorn, and watch the show before the real fireworks explode all over Washington, D.C.
Go to http://stateofthenation.co/?p=70066 to view the video news clip.
________
PCR Testing and the Genome Beast
Source: UK Column
PCR Testing and the Genome Beast
June 20, 2021
Most people believe that the PCR test is a simple test to take samples to establish whether COVID-19 is present in an individual. Some people, perhaps better informed, may know that the PCR test does not have a good reputation for accuracy in results and may give false readings. Despite this significant weakness in efficacy and accuracy, the PCR test has been promoted with almost religious zeal to the wider population by the UK Government. "Everyone should be regularly PCR tested" is the constant government line.
But is the drive for COVID-19 testing just a smokescreen with regard to the PCR test? The answer to this simple question is a straightforward yes, it is. In reality, the PCR tests have another much more important role, and that is sampling DNA data to facilitate genome sequencing, the name for reading the genetic code for the makeup of the human body.
Before COVID, the DNA sampling industry was limited to working on the medical samples to which it could gain access, together with voluntary DNA samples which an individual might offer if they passed a sample to a genealogy site to determine their family history, for example.
COVID-19 PCR tests, undertaken by millions of people, have changed this dearth of DNA data to a flood of data. And that data is worth money — a lot of money, as we shall see.
In this latest edition of No Smoke Without Fire, entitled PCR Testing and the Genome Beast, Brian Gerrish discusses with Debi Evans her research into the whole subject of genome sequencing and where it leads.
Hidden in plain sight, the genome sequencing industry is a beast of huge scale. Globally, the industry is already worth trillions of pounds, and it is expected to grow rapidly from this already immense financial base. The top ten genome sequencing companies alone had a value of over £635,000,000,000 in 2020.
Debi's interest in the PCR test began when she discovered that Illumina was the company responsible for COVID-19 PCR testing. Yet it was quickly clear that Illumina was a lot more than it might appear. As Illumina says of itself:
In the mix, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) appeared strangely silent on the subject of vaccine data. After all, it collected Yellow Card vaccine adverse reaction (ADR) data, but published no details of any safety analysis of the very data it had collected. So where does that vaccine ADR data go?
Similarly with the National Health Service (NHS): a prime collector of DNA data, but producing little public explanation as to where that data has been going and why.
Please go to UK Column to read more and view the discussion.
But is the drive for COVID-19 testing just a smokescreen with regard to the PCR test? The answer to this simple question is a straightforward yes, it is. In reality, the PCR tests have another much more important role, and that is sampling DNA data to facilitate genome sequencing, the name for reading the genetic code for the makeup of the human body.
Before COVID, the DNA sampling industry was limited to working on the medical samples to which it could gain access, together with voluntary DNA samples which an individual might offer if they passed a sample to a genealogy site to determine their family history, for example.
COVID-19 PCR tests, undertaken by millions of people, have changed this dearth of DNA data to a flood of data. And that data is worth money — a lot of money, as we shall see.
In this latest edition of No Smoke Without Fire, entitled PCR Testing and the Genome Beast, Brian Gerrish discusses with Debi Evans her research into the whole subject of genome sequencing and where it leads.
Hidden in plain sight, the genome sequencing industry is a beast of huge scale. Globally, the industry is already worth trillions of pounds, and it is expected to grow rapidly from this already immense financial base. The top ten genome sequencing companies alone had a value of over £635,000,000,000 in 2020.
Debi's interest in the PCR test began when she discovered that Illumina was the company responsible for COVID-19 PCR testing. Yet it was quickly clear that Illumina was a lot more than it might appear. As Illumina says of itself:
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.But Illumina turned out to be just one company of many. The trail led to a very large and murky pond of genome sequencing and related companies, such as Grail, the Wellcome Sanger Institute, UK Biobank, TwinsUK, Amgen, the Mayo Clinic and Genomics England — all of which overlaps with gene editing technology such as CRISPR. Governments and military also come into the picture, with ARIA and ARPA in the UK and DARPA in the USA. British academia is also well entrenched in the system, with Oxford University and Imperial College London being just two of the many institutions at the forefront.
- illumina.com
In the mix, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) appeared strangely silent on the subject of vaccine data. After all, it collected Yellow Card vaccine adverse reaction (ADR) data, but published no details of any safety analysis of the very data it had collected. So where does that vaccine ADR data go?
Similarly with the National Health Service (NHS): a prime collector of DNA data, but producing little public explanation as to where that data has been going and why.
Please go to UK Column to read more and view the discussion.
________
Here is an example of genomics:
WTF did I just hear? Please listen until the end. pic.twitter.com/bk0iIn6uI4
— Spinte.HODL ∞/21M 🍯🦡🌋 (@spinte8) June 22, 2021
News update from the UK Column for 23 June 2021:
The British are the chauffeurs of our technological data-driven futures and Covid is their energy source:
Covid booster vaccine plan to come in a few weeks - Matt Hancock
Israel? The "startup nation?" It's about linking the vaccines (injections) to extract genomic data. It is risky and they will likely fuck up a lot of children but that's what happens in economic commercial warfare monopolizing data. Going after children is paramount.
Covid booster vaccine plan to come in a few weeks - Matt Hancock
Israel? The "startup nation?" It's about linking the vaccines (injections) to extract genomic data. It is risky and they will likely fuck up a lot of children but that's what happens in economic commercial warfare monopolizing data. Going after children is paramount.
Get it?
The vaccines (injections) to start up the data-driven genomic data monopolization:
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.